Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore

Immunotherapy

  • h-index: 76
  • Total citations: 36,224
  • Total papers: 1,987
  • Impact factor: 2.4057971014492754
IMM

Immunotherapy

Journal
H-Index = 76
Citations = 36.22K+

Papers

Evidence

Recent papers in Immunotherapy

  1. Efficacy and safety of chimeric antigen receptor T-cell therapy in primary central nervous system lymphoma: a systematic review and meta-analysisImmunotherapy · Wed,
  2. From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapiesImmunotherapy · Tue,
  3. In vivo CAR-T for solid tumors: facing all the challenges of ex vivo CAR-T and moreImmunotherapy · Tue,
  4. Cancer vaccines as targeted therapies: translational advances and challengesImmunotherapy · Sat,
  5. Bromodomain inhibitors in autoimmune diseasesImmunotherapy · Sun,
  6. Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinomaImmunotherapy · Wed,
  7. Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case reportImmunotherapy · Tue,
  8. Efficacy of PARP inhibitor and immune checkpoint inhibitor combination therapy in PD-L1–negative cancers: a systematic review and meta-analysisImmunotherapy · Tue,
  9. Injection-based safety of aqueous venom immunotherapy during venom extract shortage: impact of forced depot-to-aqueous switchingImmunotherapy · Mon,
  10. Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectivesImmunotherapy · Sat,

About Immunotherapy

Immunotherapy carries 1,987 indexed papers, 36,224 citations, h-index 76 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Immunotherapy sits among the highest-credibility cardiovascular journals.

Use the feed below to follow new Immunotherapy publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 92 words.